WebApr 12, 2024 · From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $4.71 million. The company’s revenue is forecast to drop by -25.70% over what it did in 2024. A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Fulcrum Therapeutics Inc. WebApr 12, 2024 · From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $4.71 million. The company’s revenue is forecast to drop by …
FULC Stock News FULCRUM THERAPEUTICS Stock Price …
WebFULC: Get the latest Fulcrum Therapeutics stock price and detailed information including FULC news, historical charts and realtime prices. WebMar 20, 2024 · Fulcrum Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on genetically defined diseases with an initial focus on rare diseases. Fulcrum Therapeutics Inc. is based in ... government of ontario proxy form
An In-Depth Look at Fulcrum Therapeutics Inc. Inc. (FULC) Price ...
WebFind the latest Fulcrum Therapeutics, Inc. (FULC) stock quote, history, news and other vital information to help you with your stock trading and investing. Discover historical prices for FULC stock on Yahoo Finance. View daily, weekly or … Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule … See Fulcrum Therapeutics, Inc. (FULC) stock analyst estimates, including … See Fulcrum Therapeutics, Inc. (FULC) Environment, Social and Governance … View the basic FULC option chain and compare options of Fulcrum … Get the detailed quarterly/annual income statement for Fulcrum Therapeutics, Inc. … Find out the direct holders, institutional holders and mutual fund holders for … Find the latest Fulcrum Therapeutics, Inc. (FULC) stock quote, history, news and … Find the latest Fulcrum Therapeutics, Inc. (FULC) stock quote, history, news and … The latest news and headlines from Yahoo! News. Get breaking news stories and in … WebAug 10, 2024 · CAMBRIDGE, Mass., Aug. 10, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with ... WebFulcrum Therapeutics stock price target cut to $20 from $26 at Oppenheimer. Feb. 27, 2024 at 8:03 a.m. ET by Tomi Kilgore. children puzzle games free download